Aspire Biopharma Holdings, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
ASBP, ASBPW on Nasdaq
Industry
Pharmaceutical Preparations
Location
194 Candelaro Drive, #233, Humacao, PR

There are no Buy or Sell transactions made by insiders since 4/23/2024

Aspire Biopharma Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Surendra Ajjarapu Chief Executive Officer, Director, 10%+ Owner Aug 18, 2023
Howard Doss Chief Financial Officer Aug 18, 2023
L. Peterson Director Aug 18, 2023
PowerUp Sponsor LLC 10%+ Owner Aug 18, 2023
Donald Fell Director Aug 18, 2023
Bruce Hack Director Feb 17, 2022
Gabriel Schillinger President Feb 17, 2022
Michael Olson Chief Financial Officer Feb 17, 2022
Peter Blacklow Director Feb 17, 2022
Jack Tretton Chief Executive Officer, Director Feb 17, 2022
Julie Uhrman Director Feb 17, 2022
Kyle Campbell Director May 16, 2022
Avinash Wadhwani Director Aug 18, 2023
Mayur Doshi Director Aug 18, 2023

Recent Insider Transactions by Companies or Individuals for Aspire Biopharma Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.